(304 days)
Not Found
No
The device description and performance studies focus on mechanical, biocompatibility, and sterilization aspects of a physical introducer sheath system. There is no mention of software, algorithms, or data processing that would indicate the use of AI/ML.
No
The device is described as an introducer sheath system used for the introduction of other diagnostic and interventional devices, not for therapeutic treatment itself.
No
The device is an introducer sheath system, which is used for the introduction of interventional and diagnostic devices, not for performing diagnosis itself. Its description focuses on its mechanical components and function in facilitating access rather than any diagnostic capabilities.
No
The device description clearly outlines physical components (coil reinforced shaft, hemostasis valve, dilator, radiopaque marker, lubricous coating) and mentions packaging and sterilization, indicating it is a hardware device. There is no mention of software as a component or function.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is to introduce interventional and diagnostic devices into the human vasculature. This is a procedural device used within the body, not a device used to examine specimens in vitro (outside the body).
- Device Description: The description details a physical device for accessing blood vessels, not a reagent, instrument, or kit for analyzing biological samples.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), detecting analytes, or providing diagnostic information based on laboratory testing.
IVD devices are used to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. The DuraSheath Introducer Sheath System facilitates procedures within the body, which is a different category of medical device.
N/A
Intended Use / Indications for Use
The DuraSheath Introducer Sheath System is indicated to be used for introduction of interventional and diagnostic devices into the human vasculature, including but not limited to femoral access via a contralateral approach to access the popliteal and infrapopliteal arteries.
Product codes
DYB, DRE
Device Description
The DuraSheath Introducer Sheath System is a sterile, disposable device consisting of (a) a coil reinforced shaft with an atraumatic tip at the distal end; (b) a hemostasis valve with a side port and color coded 3-way stopcock; and (c) a tapered tip dilator with snap-fit hub at the proximal end. The distal end of the sheath contains a radiopaque marker. Lubricous coating is applied to the distal end of the sheath. The system is packaged inside a sealed Tyvek pouch.
The DuraSheath Introducer Sheath System is a prescription medical device that is used only in healthcare facilities or hospitals. The device is placed in patients for up to 24 hours.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
human vasculature, femoral access via a contralateral approach to access the popliteal and infrapopliteal arteries
Indicated Patient Age Range
Not Found
Intended User / Care Setting
healthcare facilities or hospitals.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Nonclinical and clinical performance data demonstrate that the DuraSheath Introducer Sheath System is safe and effective and performs substantially equivalent to the predicates. The following performance data from non-clinical tests are being provided in support of the substantial equivalence determination:
- Mechanical testing, including tests required under relevant international standards, coating adhesion and particulate testing, and transportation integrity testing, performed to verify and validate the design and to demonstrate process capability.
- Full range of Biocompatibility testing to demonstrate biocompatibility.
- Sterilization Validation Adoption to confirm sterility of the device upon exposure to the selected sterilization cycle.
- Accelerated age testing to confirm product performance and end of shelf life.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1340 Catheter introducer.
(a)
Identification. A catheter introducer is a sheath used to facilitate placing a catheter through the skin into a vein or artery.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized caduceus symbol, which is often associated with healthcare. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the caduceus. The logo is simple and professional, reflecting the department's role in public health and human services.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
June 24, 2015
Contract Medical International GmbH Jan Kloboucnik Director, Regulatory and Quality Affairs Lauensteiner Str, 37 Dresden, 01277 DE
Re: K142357
Trade/Device Name: DuraSheath Introducer Sheath System Regulation Number: 21 CFR 870.1340 Regulation Name: Catheter Introducer Regulatory Class: Class II Product Code: DYB. DRE Dated: May 21, 2015 Received: May 26, 2015
Dear Jan Kloboucnik,
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR
1
Part 807); labeling (21 CFR Part 801); medical device reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
M.A. Hillebrenner
for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
510(k) Number (if known) K142357
Device Name DuraSheath Introducer Sheath System
Indications for Use (Describe)
The DuraSheath Introducer Sheath System is indicated to be used for introduction of interventional and diagnostic devices into the human vasculature, including but not limited to femoral access via a contralateral approach to access the popliteal and infrapopliteal arteries.
| Type of Use (Select one or both, as applicable) | ||||
|---|---|---|---|---|
| X Prescription Use (Part 21 CFR 801 Subpart D) | Over=The-Counter Use (21 CFR 801 Subpart C) | |||
| CONTINUE ON A SEPARATE PAGE IF NEEDED. | ||||
| This section applies only to requirements of the Paperwork Reduction Act of 1995. | ||||
| DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW. | ||||
| The burden time for this collection of information is estimated to average 79 hours per response, including the | ||||
| time to review instructions, search existing data sources, gather and maintain the data needed and complete | ||||
| and review the collection of information. Send comments regarding this burden estimate or any other aspect | ||||
| of this information collection, including suggestions for reducing this burden, to: | ||||
| Food and Drug Administration | ||||
| Office of Chief Information Officer | ||||
| Paperwork Reduction Act (PRA) Staff | ||||
| PRAStaff(@fda.hhs.gov | Department of Health and Human Services |
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
K142357 - 510(k) Summary
1.1 Submitter
| Submitter: | Contract Medical International GmbH
Lauensteiner Straße 37
01277 Dresden
Germany |
|-----------------|-------------------------------------------------------------------------------------------|
| Contact Person: | Jan Kloboucnik, Director, RA/QA |
| Phone: | +420 494 949 564 |
| Fax: | +420 494 949 565 |
| Email: | jkloboucnik@contract-medical.com |
| Date Prepared: | 24 June 2015 |
1.2 Device
| Device Trade Name: | DuraSheath Introducer Sheath System |
|---|---|
| Device Common Name: | Introducer Sheath |
| Classification Name: | Introducer, Catheter; and |
| Dilator, Vessel, For Percutaneous Catheterization | |
| Regulatory Class: | II |
| Product Code: | DYB; and |
| DRE |
Predicate Device 1.3
| Primary Predicate Device: | Pinnacle Destination Guiding Sheath
(K091329) |
|---------------------------|--------------------------------------------------|
| Second Predicate Device: | Fortress Introducer Sheath System
(K100799) |
1.4 Device Description
The DuraSheath Introducer Sheath System is a sterile, disposable device consisting of (a) a coil reinforced shaft with an atraumatic tip at the distal end; (b) a hemostasis valve with a side port and color coded 3-way stopcock; and (c) a tapered tip dilator with snap-fit hub at the proximal end. The distal end of the sheath contains a radiopaque marker. Lubricous coating is applied to the distal end of the sheath. The system is packaged inside a sealed Tyvek pouch.
The DuraSheath Introducer Sheath System is a prescription medical device that is used only in healthcare facilities or hospitals. The device is placed in patients for up to 24 hours.
4
1.5 Indications for Use
The DuraSheath Introducer Sheath System is indicated to be used for introduction of interventional and diagnostic devices into the human vasculature, including but not limited to femoral access via a contralateral approach to access the popliteal and infrapopliteal arteries.
The Indications for Use statement for the DuraSheath Introducer Sheath System is not identical to that of the two predicate devices; however, the differences do not alter the intended use of the device nor do they affect the safety and effectiveness of the device relative to the predicate devices. The DuraSheath Introducer Sheath System and the two predicate devices each have the same intended use, namely to support the introduction of interventional and diagnostic devices.
1.6 Comparison of Technological Characteristics with the Predicate Device
The DuraSheath Introducer Sheath System is a manually operated, sterile, single patient use sheath system made predominantly of thermoplastic polymers. The sheath is reinforced with a stainless steel coil in order to provide kink resistance when passed through tortuous paths. With regard to the design, device features, method of sterilization, and mode of operation, the DuraSheath Introducer Sheath System does not differ from the predicate devices. Materials used for manufacture of the DuraSheath Introducer Sheath System are the same or very similar to those contained in the predicate devices. Technological characteristics of the subject device differ from those of the predicates only with respect to materials for selected components and the choice of lubricious coating on the sheath. Both the polyurethane used for the outer layer and the hydrophobic coating applied to the distal end of the sheath of the DuraSheath Introducer Sheath System are commonly used in medical devices, including introducer sheaths and catheters. Differences in technological characteristics between the subject device and the predicates do not raise and concerns of safety and effectiveness, as demonstrated by the performance data collected.
1.7 Performance Data
Nonclinical and clinical performance data demonstrate that the DuraSheath Introducer Sheath System is safe and effective and performs substantially equivalent to the predicates. The following performance data from non-clinical tests are being provided in support of the substantial equivalence determination:
- Mechanical testing, including tests required under relevant international standards, coating adhesion and particulate testing, and transportation integrity testing, performed to verify and validate the design and to demonstrate process capability.
- Full range of Biocompatibility testing to demonstrate biocompatibility. ●
- Sterilization Validation Adoption to confirm sterility of the device upon exposure to the selected sterilization cycle.
- . Accelerated age testing to confirm product performance and end of shelf life.
5
1.8 Conclusions
Results demonstrate that the DuraSheath Introducer Sheath System performs comparably with predicates and other legally marketed devices. The DuraSheath Introducer Sheath System is substantially equivalent to the two predicates devices in terms of intended use, design and materials, technological characteristics, and principle of operation. Any differences between the subject device and the predicates do not raise any issues of safety or effectiveness.